OPKO Health Inc (NASDAQ:OPK)
| 5.26 Delayed Data As of Jan 26 |  +0.24 / +4.78%Today’s Change | 1.12 Today|||52-Week Range 6.47 | +33.04% Year-to-Date |
Latest OPK News | Press Releases
| OPKO Health's (OPK) BioReference Extends Digital Health Access Jan 14 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 5.02 |
| Today’s open | 5.09 |
| Day’s range | 4.85 - 5.52 |
| Volume | 16,902,123 |
| Average volume (3 months) | 8,776,103 |
| Market cap | $3.0B |
Data as of 4:17pm ET, 01/26/2021
Growth & Valuation
| Earnings growth (last year) | -94.59% |
| Earnings growth (this year) | +104.15% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | -8.92% |
| P/E ratio | NM |
| Price/Sales | 0.97 |
| Price/Book | 1.83 |
Competitors
| ---- | ||
| CORTCorcept Therapeutics... | -0.04 | -0.14% |
| AGIOAgios Pharmaceutical... | -1.46 | -2.95% |
| APLSApellis Pharmaceutic... | -1.40 | -3.02% |
Data as of 7:25pm ET, 01/26/2021
Financials
| Next reporting date | March 3, 2021 |
| EPS forecast (this quarter) | $0.04 |
| Annual revenue (last year) | $901.9M |
| Annual profit (last year) | -$314.9M |
| Net profit margin | -34.92% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Miami, Florida |
Forecasts
